Current issues in child and adolescent psychopharmacology. Part 2: Anxiety and obsessive-compulsive disorders, autism, Tourette's and schizophrenia

Advances in Psychiatric Treatment

Volumn 9, Issue 4, 2003, Pages 289-299

  Coghill, Dave ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIANDROGEN; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CALCIUM CHANNEL BLOCKING AGENT; CLOMIPRAMINE; CLONIDINE; CLOZAPINE; DESIPRAMINE; FENFLURAMINE; FLUVOXAMINE; GASTROINTESTINAL POLYPEPTIDE; HALOPERIDOL; METHYLPHENIDATE; NALTREXONE; NEUROLEPTIC AGENT; OLANZAPINE; PIMOZIDE; PLACEBO; PSYCHOSTIMULANT AGENT; QUETIAPINE; RISPERIDONE; SECRETIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SULPIRIDE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZIPRASIDONE;

ADOLESCENT; AGGRESSION; AGRANULOCYTOSIS; AKATHISIA; ANXIETY DISORDER; AUTISM; BEHAVIOR THERAPY; BODY WEIGHT DISORDER; CARDIOTOXICITY; CHILD; CHILD PSYCHIATRY; CLINICAL RESEARCH; CLINICAL TRIAL; DROWSINESS; DRUG DEPENDENCE; DRUG EFFICACY; DYSKINESIA; DYSTONIA; EDUCATION; EVIDENCE BASED MEDICINE; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; GILLES DE LA TOURETTE SYNDROME; HEADACHE; HUMAN; HYPERSALIVATION; INSOMNIA; LIVER TOXICITY; LONG QT SYNDROME; MANIA; NAUSEA; NEUTROPENIA; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; PARKINSONISM; PSYCHOPHARMACOTHERAPY; REVIEW; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; TARDIVE DYSKINESIA; VERTIGO; WITHDRAWAL SYNDROME;

EID: 0012311721     PISSN: 13555146     EISSN: None     Source Type: Journal    
DOI: 10.1192/apt.9.4.289     Document Type: Review

References (58)

1. American Academy of Child and Adolescent Psychiatry (2001) Practice parameter for the assessment and treatment of children and adolescents with schizophrenia (American Academy of Child and Adolescent Psychiatry). Journal of the American Academy of Child and Adolescent Psychiatry, 40, 4S-23S.
2. Bhangoo, R. K.&Riddle, M. A. (1999) Pharmacological treatment of anxiety disorders in adolescents. In Adolescent Psychiatry (vol. 24) (ed. A. Eisman), pp. 243-270. Hillsdale, NJ: Analytic Press.
3. Bolton, J., Moore, G. J., MacMillan, S., et al (2001) Case study: caudate glutamatergic changes with paroxetine persist after medication discontinuation in pediatric OCD. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 903-906.
4. Bruggeman, R., van der Linden, C., Buitelaar, J. K., et al (2001) Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study. Journal of Clinical Psychiatry, 62, 50-56.
5. Buitelaar, J. K.&Willemsen-Swinkels, S. H. (2000) Medication treatment in subjects with autistic spectrum disorders. European Child and Adolescent Psychiatry, 9 (suppl. 1), 185-197.
6. Campbell, M., Armenteros, J. L., Malone, R. P., et al (1997) Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 835-843.
7. Castellanos, F. X., Giedd, J. N., Elia, J., et al (1997) Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 589-596.
8. Coffey, B. J. (1990) Anxiolytics for children and adolescents: Traditional and new drugs. Journal of Child and Adolescent Psychopharmacology, 1, 57-83.
9. Coghill, D. (2003) Current issues in child and adolescent psychopharmacology. Part 1: Attention-deficit hyperactivity disorder and affective disorders. Advances in Psychiatric Treatment, 9, 86-94.
10. Cook, E. H., Wagner, K. D., March, J. S., et al (2001) Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 1175-1181.
11. Cozza, S. J.&Edison, D. L. (1994) Risperidone in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 1211.
12. Dion, Y., Annable, L., Sandor, P., et al (2002) Risperidone in the treatment of Tourette syndrome: a double-blind, placebo-controlled trial. Journal of Clinical Psychopharmacology, 22, 31-39.
13. Feldman, H. M., Kolmen, B. K.,&Gonzaga, A. M. (1999) Naltrexone and communication skills in young children with autism. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 587-593.
14. Findling, R. L., McNamara, N. K.,&Gracious, B. L. (2000) Paediatric uses of atypical antipsychotics. Expert Opinion on Pharmacotherapy, 1, 935-945.
15. Geller, D. A., Hoog, S. L., Heiligenstein, J. H., et al (2001) Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 773-779.
16. Gordon, C. T., Rapoport, J. L., Hamburger, S. D., et al (1992) Differential response of seven subjects with autistic disorder to clomipramine and desipramine. American Journal of Psychiatry, 149, 363-366.
17. Gordon, C. T., State, R. C., Nelson, J. E., et al (1993) A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Archives of General Psychiatry, 50, 441-447.
18. Grados, M. A.&Riddle, M. A. (2001) Pharmacological treatment of childhood obsessive-compulsive disorder: from theory to practice. Journal of Clinical Child Psychology, 30, 67-79.
19. Grados, M. A., Scahill, L.&Riddle, M. A. (1999) Pharmacotherapy in children and adolescents with obsessive-compulsive disorder. Child and Adolescent Psychiatric Clinics of North America, 8, 617-634.
20. Hardan, A., Johnson, K., Johnson, C., et al (1996) Case study: risperidone treatment of children and adolescents with developmental disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1551-1556.
21. Jensen, P. S., Hinshaw, S. P., Kraemer, H. C., et al (2001) ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 147-158.
22. Kumra, S. (2000) The diagnosis and treatment of children and adolescents with schizophrenia. "My mind is playing tricks on me". Child and Adolescent Psychiatric Clinics of North America, 9, 183-199.
23. Kumra, S., Frazier, J. A., Jacobsen, L. K., et al (1996) Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison. Archives of General Psychiatry, 53, 1090-1097.
24. Malone, R. P., Cater, J., Sheikh, R. M., et al (2001) Olanzapine versus haloperidol in children with autistic disorder: an open pilot study. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 887-894.
25. Mandoki, M. W. (1995) Risperidone treatment of children and adolescents: Increased risk of extrapyramidal side effects? Journal of Child and Adolescent Psychopharmacology, 5, 49-57.
26. March, J. S., Biederman, J., Wolkow, R., et al (1998) Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. JAMA, 280, 1752-1756.
27. March, J. S., Swanson, J. M., Arnold, L. E., et al (2000) Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA). Journal of Abnormal Child Psychology, 28, 527-541.
28. Martin, A., Koenig, K., Scahill, L., et al (1999) Open-label quetiapine in the treatment of children and adolescents with autistic disorder. Journal of Child and Adolescent Psychopharmacology, 9, 99-107.
29. McCracken, J. T., McGough, J., Shah, B., et al (2002) Risperidone in children with autism and serious behavioral problems. New England Journal of Medicine, 347, 314-321.
30. McDougle, C. J., Naylor, S. T., Cohen, D. J., et al (1996) A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Archives of General Psychiatry, 33, 1001-1008.
31. McDougle, C. J., Naylor, S. T., Bronson, M. R., et al (1997) Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 685-693.
32. McDougle, C. J., Naylor, S. T., Carlson, D. C., et al (1998) A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Archives of General Psychiatry, 55, 633-641.
33. McDougle, C. J., Scahill, L., McCracken, J. T., et al (2000) Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone. Child and Adolescent Psychiatric Clinics of North America, 9, 201-224.
34. MTA Cooperative Group (1999) Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1088-1096.
35. Nicolson, R., Awad, G.&Sloman, L. (1998) An open trial of risperidone in young autistic children. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 372-376.
36. Onofrj, M., Paci, C., D'Andreamatteo, G., et al (2000) Olanzapine in severe Gilles de la Tourette syndrome: a 52-week double-blind cross-over study vs. low-dose pimozide. Journal of Neurology, 247, 443-446.
37. Perry, R., Pataki, C., Munoz-Silva, D. M., et al (1997) Risperidone in children and adolescents with pervasive developmental disorder: pilot trial and follow-up. Journal of Child and Adolescent Psychopharmacology, 7, 167-179.
38. Pfeffer, C. R., Jiang, H.&Domeshek, L. J. (1997) Buspirone treatment of psychiatrically hospitalized prepubertal children with symptoms of anxiety and moderately severe aggression. Journal of Child and Adolescent Psychopharmacology, 7, 145-155.
39. Pine, D. S., Cohen, P., Gurley, D., et al (1998) The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Archives of General Psychiatry, 55, 56-64.
40. Pliszka, S. R., Greenhill, L. L., Crismon, M. L., et al (2000) The Texas Children's Medication Algorithm Project: a report of the Texas Consensus Conference Panel on medication treatment of childhood attention-deficit/hyperactivity disorder. Part I. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 908-919.
41. Pool, D., Bloom, W., Mielke, D. H., et al (1976) A controlled evaluation of loxitane in seventy-five adolescent schizophrenic patients. Current Therapeutic Research: Clinical and Experimental, 19, 99-104.
42. Potenza, M. N., Holmes, J. P., Kanes, S. J., et al (1999) Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study. Journal of Clinical Psychopharmacology, 19, 37-44.
43. Quintana, H., Birmaher, B., Stedge, D., et al (1995) Use of methylphenidate in the treatment of children with autistic disorder. Journal of Autism and Developmental Disorders, 25, 283-294.
44. Research Unit on Pediatric Psychopharmacology Anxiety Study Group (2001) Fluvoxamine for the treatment of anxiety disorders in children and adolescents. New England Journal of Medicine, 344, 1279-1285.
45. Riddle, M. A., Reeve, E. A., Yaryura-Tobias, J. A., et al (2001) Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 222-229.
46. Robertson, M. M.&Stern, J. S. (2000) Gilles de la Tourette syndrome: symptomatic treatment based on evidence. European Child and Adolescent Psychiatry, 9 (suppl. 1), 160-175.
47. Rosenberg, D. R., MacMillan, S. N.&Moore, G. J. (2001) Brain anatomy and chemistry may predict treatment response in paediatric obsessive-compulsive disorder. International Journal of Neuropsychopharmacology, 4, 179-190.
48. Rynn, M. A., Siqueland, L.&Rickels, K. (2001) Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. American Journal of Psychiatry, 158, 2008-2014.
49. Sallee, F. R., Kurlan, R., Goetz, C. G., et al (2000) Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 292-299.
50. Singer, H. S., Brown, J., Quaskey, S., et al (1995) The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine. Pediatrics, 95, 74-81.
51. Spencer, E. K., Kafantaris, V., Padron-Gayol, M. V., et al (1992) Haloperidol in schizophrenic children: early findings from a study in progress. Psychopharmacology Bulletin, 28, 183-186.
52. Spencer, T., Biederman, J., Wilens, T., et al (1993) Nortriptyline treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 205-210.
53. Thomsen, P. H. (2000) Obsessive-complusive disorder: pharmacological treatment. European Child and Adolescent Psychiatry, 9 (suppl. 1), 176-184.
54. Thomsen, P. H.,&Leckman, J. (2000) Obsessive compulsive disorder and anxiety spectrum in children and adolescents. CNS Spectrums, 6, 18-23.
55. Thomsen, P. H., Ebbesen, C.&Persson, C. (2001) Long-term experience with citalopram in the treatment of adolescent OCD. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 895-902.
56. Velosa, J. F.&Riddle, M. A. (2000) Pharmacologic treatment of anxiety disorders in children and adolescents. Child and Adolescent Psychiatric Clinics of North America, 9, 119-133.
57. Yung, A. R., Phillips, L. J., McGorry, P. D., et al (1998) Prediction of psychosis. A step towards indicated prevention of schizophrenia. British Journal of Psychiatry, 172 (suppl. 33), 14-20.
58. Zuddas, A., Ledda, M. G., Fratta, A., et al (1996) Clinical effects of clozapine on autistic disorder. American Journal of Psychiatry, 153, 738.